Data as of Nov 21
| +0.054 / +2.50%|
The 1 analysts offering 12-month price forecasts for X T L Biopharmaceuticals Ltd have a median target of 14.00, with a high estimate of 14.00 and a low estimate of 14.00. The median estimate represents a +532.34% increase from the last price of 2.21.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.